Article
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Strong Bullish
100.0
−100 Bearish
0
+100 Bullish
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Strong Bullish
100.0
−100Neutral+100
More Like This